Atlas Brown’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $623K | Buy |
9,025
+933
| +12% | +$64.4K | 0.2% | 107 |
|
|
2025
Q1 | $562K | Buy |
8,092
+2,962
| +58% | +$206K | 0.2% | 111 |
|
|
2024
Q4 | $441K | Buy |
5,130
+1,285
| +33% | +$111K | 0.15% | 133 |
|
|
2024
Q3 | $458K | Sell |
3,845
-438
| -10% | -$52.2K | 0.16% | 132 |
|
|
2024
Q2 | $611K | Buy |
4,283
+460
| +12% | +$65.7K | 0.22% | 108 |
|
|
2024
Q1 | $491K | Buy |
3,823
+95
| +3% | +$12.2K | 0.18% | 117 |
|
|
2023
Q4 | $386K | Hold |
3,728
| – | – | 0.16% | 128 |
|
|
2023
Q3 | $339K | Hold |
3,728
| – | – | 0.15% | 132 |
|
|
2023
Q2 | $302K | Hold |
3,728
| – | – | 0.13% | 142 |
|
|
2023
Q1 | $297K | Buy |
3,728
+8
| +0.2% | +$637 | 0.14% | 139 |
|
|
2022
Q4 | $252K | Buy |
+3,720
| New | +$252K | 0.12% | 153 |
|
|
2022
Q3 | – | Sell |
-3,720
| Closed | -$207K | – | 174 |
|
|
2022
Q2 | $207K | Hold |
3,720
| – | – | 0.1% | 165 |
|
|
2022
Q1 | $207K | Hold |
3,720
| – | – | 0.08% | 180 |
|
|
2021
Q4 | $208K | Buy |
+3,720
| New | +$208K | 0.08% | 184 |
|